Salarius Pharmaceuticals
SLRX
SLRX
22 hedge funds and large institutions have $29.5M invested in Salarius Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
83% less call options, than puts
Call options by funds: $9K | Put options by funds: $53K
Holders
22
Holding in Top 10
–
Calls
$9K
Puts
$53K
Top Buyers
| 1 | +$1.22M | |
| 2 | +$762K | |
| 3 | +$360K | |
| 4 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$264K |
Top Sellers
| 1 | -$2.16M | |
| 2 | -$1.67M | |
| 3 | -$1.44M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$720K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$598K |